Unitree Technology released a statement noting that the cumulative deviation in its stock's closing price over three consecutive trading days surpassed 30%, signaling abnormal volatility in stock trading. As of October 26, 2026, the company's trailing price-to-earnings (P/E) ratio stood at 465.22, markedly higher than the industry average of 38.54 for the general equipment manufacturing sector. Presently, the humanoid robot industry remains in the nascent stages of commercialization, with uncertainties surrounding technological readiness, downstream market demand, and supply chain capabilities. Moreover, the large-scale application of embodied AI technology—transitioning from laboratory demonstrations to real-world use—still grapples with several challenges, such as perception accuracy, motion control stability, data accumulation, and hardware-software integration. It will require time for the relevant technological approaches and business models to reach maturity. Should large-scale commercialization in the industry fail to meet expectations, the company's future revenue and performance could be negatively impacted, leading to potential risks of valuation adjustments.